![FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire](https://mms.businesswire.com/media/20171130006320/en/627349/5/FMI_Exterior_for_Press_Kit.jpg)
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
![Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire](https://mms.businesswire.com/media/20200212005980/en/773224/5/FMI_vertical-slate.jpg)
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire
![Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History](https://cdn.sanity.io/images/ti7si9cx/production/027cc19cfe86f324fb5ec461e5b519bb58a0ea29-1500x750.jpg?w=1382)
Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History
![Buy Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Components) Book Online at Low Prices in India | Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Buy Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Components) Book Online at Low Prices in India | Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite](https://m.media-amazon.com/images/I/61ttR2hOjgL._AC_UF1000,1000_QL80_.jpg)
Buy Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Components) Book Online at Low Prices in India | Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite
![Foundation Medicine Rotation for Residents is Underway, and to Great Reviews! | Duke Department of Pathology Foundation Medicine Rotation for Residents is Underway, and to Great Reviews! | Duke Department of Pathology](https://pathology.duke.edu/sites/default/files/styles/freeform_scaled/public/2022-04/duke_foundation_logo_news_0.png?itok=IsoV78ry)